Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. (Q53642127)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. |
scientific article |
Statements
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. (English)
Allan L Drash
Dorothy J Becker
Massimo Pietropaolo
Shui Yu
Ingrid M Libman
Susan L Pietropaolo
Karen Riley
Ronald E LaPorte
Sati Mazumdar
Massimo Trucco
1 December 2005
6
4
184-192